Literature DB >> 11284711

The molecular basis of oculocutaneous albinism type 1 (OCA1): sorting failure and degradation of mutant tyrosinases results in a lack of pigmentation.

K Toyofuku1, I Wada, R A Spritz, V J Hearing.   

Abstract

Oculocutaneous albinism type 1 (OCA1) is an autosomal recessive disease resulting from mutations of the tyrosinase gene (TYR). To elucidate the molecular basis of OCA1 phenotypes, we analysed the early processing and maturation of several different types of mutant tyrosinase with various degrees of structural abnormalities (i.e. two large deletion mutants, two missense mutants that completely destroy catalytic function and three missense mutants that have a temperature-sensitive phenotype). When expressed in COS7 cells, all mutant tyrosinases were sensitive to endoglycosidase H digestion, and immunostaining showed their localization in the endoplasmic reticulum (ER) and their failure to be sorted further to their target organelles. Pulse-chase experiments showed that all mutant tyrosinases were retained by calnexin in the ER and that they were degraded at similarly rapid rates, which coincided with their dissociation from calnexin. Temperature-sensitive mutant enzymes were sorted more efficiently at 31 degrees C than at 37 degrees C, and their degradation was accelerated at 37 degrees C compared with 31 degrees C. Thus in contrast to the current concept that mutant tyrosinases are transported to melanosomes but are functionally inactive there, our results suggest that mutant tyrosinases may not be transported to melanosomes in the first place. We conclude that a significant component of mutant tyrosinase malfunction in OCA1 results from their retention and degradation in the ER compartment. This quality-control process is highly sensitive to minimal changes in protein folding, and so even relatively minor mutations in peripheral sequences of the enzyme not involved with catalytic activity may result in a significant reduction of functional enzyme in melanosomes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11284711      PMCID: PMC1221735          DOI: 10.1042/0264-6021:3550259

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  46 in total

1.  A cytoplasmic sequence in human tyrosinase defines a second class of di-leucine-based sorting signals for late endosomal and lysosomal delivery.

Authors:  P A Calvo; D W Frank; B M Bieler; J F Berson; M S Marks
Journal:  J Biol Chem       Date:  1999-04-30       Impact factor: 5.157

2.  Promotion of tyrosinase folding in COS 7 cells by calnexin.

Authors:  K Toyofuku; I Wada; K Hirosaki; J S Park; Y Hori; K Jimbow
Journal:  J Biochem       Date:  1999-01       Impact factor: 3.387

3.  Sec61-mediated transfer of a membrane protein from the endoplasmic reticulum to the proteasome for destruction.

Authors:  E J Wiertz; D Tortorella; M Bogyo; J Yu; W Mothes; T R Jones; T A Rapoport; H L Ploegh
Journal:  Nature       Date:  1996-12-05       Impact factor: 49.962

4.  Detection of mutations in the tyrosinase gene in a patient with type IA oculocutaneous albinism.

Authors:  R A Spritz; K M Strunk; L B Giebel; R A King
Journal:  N Engl J Med       Date:  1990-06-14       Impact factor: 91.245

Review 5.  Melanosomes are specialized members of the lysosomal lineage of organelles.

Authors:  S J Orlow
Journal:  J Invest Dermatol       Date:  1995-07       Impact factor: 8.551

6.  Inhibition of glucose trimming with castanospermine reduces calnexin association and promotes proteasome degradation of the alpha-subunit of the nicotinic acetylcholine receptor.

Authors:  S H Keller; J Lindstrom; P Taylor
Journal:  J Biol Chem       Date:  1998-07-03       Impact factor: 5.157

7.  Proteasome-mediated degradation of apolipoprotein B targets both nascent peptides cotranslationally before translocation and full-length apolipoprotein B after translocation into the endoplasmic reticulum.

Authors:  W Liao; S C Yeung; L Chan
Journal:  J Biol Chem       Date:  1998-10-16       Impact factor: 5.157

8.  Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin.

Authors:  G Fenteany; R F Standaert; W S Lane; S Choi; E J Corey; S L Schreiber
Journal:  Science       Date:  1995-05-05       Impact factor: 47.728

9.  Folding and oligomerization of influenza hemagglutinin in the ER and the intermediate compartment.

Authors:  U Tatu; C Hammond; A Helenius
Journal:  EMBO J       Date:  1995-04-03       Impact factor: 11.598

10.  Induction of pigmentation in mouse fibroblasts by expression of human tyrosinase cDNA.

Authors:  B Bouchard; B B Fuller; S Vijayasaradhi; A N Houghton
Journal:  J Exp Med       Date:  1989-06-01       Impact factor: 14.307

View more
  27 in total

1.  Next-generation DNA re-sequencing identifies common variants of TYR and HLA-A that modulate the risk of generalized vitiligo via antigen presentation.

Authors:  Ying Jin; Tracey Ferrara; Katherine Gowan; Cherie Holcomb; Melinda Rastrou; Henry A Erlich; Pamela R Fain; Richard A Spritz
Journal:  J Invest Dermatol       Date:  2012-03-08       Impact factor: 8.551

2.  Pink-eyed dilution protein controls the processing of tyrosinase.

Authors:  Kun Chen; Prashiela Manga; Seth J Orlow
Journal:  Mol Biol Cell       Date:  2002-06       Impact factor: 4.138

Review 3.  Mechanisms of protein delivery to melanosomes in pigment cells.

Authors:  Anand Sitaram; Michael S Marks
Journal:  Physiology (Bethesda)       Date:  2012-04

4.  Temperature sensitive oculocutaneous albinism associated with missense changes in the tyrosinase gene.

Authors:  T Wang; C T Waters; T Jakins; J R W Yates; D Trump; K Bradshaw; A T Moore
Journal:  Br J Ophthalmol       Date:  2005-10       Impact factor: 4.638

5.  Identifying genes underlying skin pigmentation differences among human populations.

Authors:  Sean Myles; Mehmet Somel; Kun Tang; Janet Kelso; Mark Stoneking
Journal:  Hum Genet       Date:  2006-09-15       Impact factor: 4.132

6.  Mutations in dopachrome tautomerase (Dct) affect eumelanin/pheomelanin synthesis, but do not affect intracellular trafficking of the mutant protein.

Authors:  Gertrude-E Costin; Julio C Valencia; Kazumasa Wakamatsu; Shosuke Ito; Francisco Solano; Adina L Milac; Wilfred D Vieira; Yuji Yamaguchi; François Rouzaud; Andrei-J Petrescu; M Lynn Lamoreux; Vincent J Hearing
Journal:  Biochem J       Date:  2005-10-15       Impact factor: 3.857

7.  Posttranscriptional Regulation of Glycoprotein Quality Control in the Endoplasmic Reticulum Is Controlled by the E2 Ub-Conjugating Enzyme UBC6e.

Authors:  Masatoshi Hagiwara; Jingjing Ling; Paul-Albert Koenig; Hidde L Ploegh
Journal:  Mol Cell       Date:  2016-08-25       Impact factor: 17.970

8.  Normal tissue depresses while tumor tissue enhances human T cell responses in vivo to a novel self/tumor melanoma antigen, OA1.

Authors:  Christopher E Touloukian; Wolfgang W Leitner; Rhonda E Schnur; Paul F Robbins; Yong Li; Scott Southwood; Alessandro Sette; Steven A Rosenberg; Nicholas P Restifo
Journal:  J Immunol       Date:  2003-02-01       Impact factor: 5.422

9.  Differential gene expression of TRPM1, the potential cause of congenital stationary night blindness and coat spotting patterns (LP) in the Appaloosa horse (Equus caballus).

Authors:  Rebecca R Bellone; Samantha A Brooks; Lynne Sandmeyer; Barbara A Murphy; George Forsyth; Sheila Archer; Ernest Bailey; Bruce Grahn
Journal:  Genetics       Date:  2008-07-27       Impact factor: 4.562

Review 10.  Role of the ubiquitin proteasome system in regulating skin pigmentation.

Authors:  Hideya Ando; Masamitsu Ichihashi; Vincent J Hearing
Journal:  Int J Mol Sci       Date:  2009-11-20       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.